Corneal Cross-Linking via Apical Epithelial Ablation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing treatments for disorders such as keratoconus and post-LASIK ectasia face challenges in efficiently delivering cross-linking agents and photoactivating light to the cornea, particularly due to the impermeability of the corneal epithelium and the need for precise control over cross-linking depth and distribution.
Innovation Solution
The system employs a laser or mechanical disruptor to ablate the apical layers of the corneal epithelium, allowing for enhanced permeability and precise delivery of cross-linking agents like riboflavin, combined with controlled photoactivating light to induce cross-linking reactions, utilizing parameters like wavelength, intensity, and oxygen concentration to optimize treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the corneal epithelium is left intact, then the cornea is protected from external factors, but the cross-linking agent cannot efficiently penetrate to the target tissue
Solution Approach 1:
The corneal epithelium is selectively segmented by removing only the apical layers (superficial squamous cells) while preserving the deeper epithelial layers. This partial disruption creates localized pathways for cross-linking agent penetration while maintaining the overall protective barrier function of the intact epithelium.
Solution Approach 2:
The treatment creates local changes in epithelial permeability only in the treatment zone by disrupting apical layers, while the surrounding epithelium remains intact and protective. This localized modification allows targeted cross-linking agent delivery without compromising overall corneal protection.
2Quantity of substance
If the corneal epithelium is completely removed to enhance permeability, then cross-linking agent delivery is improved, but patient discomfort increases and complications arise
Solution Approach 1:
Instead of complete epithelial removal, only a partial disruption of the apical layers is performed. This partial action is sufficient to enhance cross-linking agent penetration while avoiding the severe discomfort and complications associated with full epithelial removal.
Solution Approach 2:
The deeper epithelial layers are preserved beforehand to serve as a protective cushion and barrier. These intact layers prevent direct exposure of underlying nerves and tissues, thereby cushioning against patient discomfort and reducing the risk of infections and other complications.
3Object-affected harmful factors
If cross-linking treatment is applied without disrupting the epithelium, then patient comfort is maintained, but the treatment time increases and effectiveness decreases
Solution Approach 1:
The epithelium is segmented into disrupted apical layers and intact deeper layers. This segmentation creates efficient pathways for cross-linking agent delivery, significantly reducing treatment time and enhancing effectiveness while the intact deeper layers maintain patient comfort by preserving nerve protection.
4Strength
If the cross-linking treatment targets deep corneal layers, then structural strengthening is achieved, but the risk of over-penetration and damage increases
Solution Approach 1:
The apical epithelial layers are disrupted beforehand to create controlled pathways that guide cross-linking agent delivery. This preliminary action ensures that the agent reaches the target deep corneal layers through predefined channels, achieving structural strengthening while minimizing the risk of uncontrolled over-penetration and tissue damage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach achieves more efficient and precise cross-linking of corneal collagen, reducing treatment time, minimizing patient discomfort, and avoiding complications associated with full epithelial removal, while enhancing corneal strength and stability.
Implementation Method 1
The example treatments disrupt tissue at the area at the surface of the cornea up to a depth corresponding to apical layers of superficial squamous cells of the cornea
Implementation Method 2
The cross-linking agent is transmitted through the disrupted area at a greater rate relative to non-disrupted areas of the cornea
Implementation Method 3
The photoactivating light activates the cross-linking agent to generate cross-linking activity in the cornea
Data Source
AI summary
Example eye treatments detennine an area at a surface of a cornea for delivery of a cross-linking agent. The example treatments disrupt tissue at the area at the surface of the conlea up to a depth corresponding to apical layers of superficial squamous cells of the cornea, e.g., no greater than approximately 10 μm to approximately 15 lm. The example treatments apply a cross-linking agent to the area at the surface of the cornea. The cross-linking agent is transmitted through the disrupted area at a greater rate relative to non disrupted areas of the cornea. The example treatments deliver photoactivating light to the cornea. The photoactivating light activates the cross-linking agent to generate cross-linking activity in the cornea.